Madam Speaker, the member opposite is right. The interim order does allow, if possible, early placement of vaccines that have not been approved by Health Canada. Usually vaccines and any other medical product that are not approved by Health Canada are stopped from entering into Canada, but, in this case, companies can apply for an exemption to that rule and place it early.
I want to thank the Minister of Public Services and Procurement for doing the incredible yeoman's work of ensuring that we have such a diverse portfolio and such good relationships, on top of that, with the manufacturers of seven promising candidates, including Pfizer, Moderna, AstraZeneca, Janssen and all of the others that are in the queue.
What is really promising is that four of those companies have applied for regulatory approval. In fact, we were one of the first countries to receive all four applying to Canada. It is an indication of just how positive that relationship is between the minister, our government and these manufacturing companies.